ORPHENADRINE CITRATE
Orphenadrine Citrate Extended-Release Tablets
Approved
Approval ID
28d5753e-862a-4811-8b9f-6707361f8475
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 29, 2010
Manufacturers
FDA
Physicians Total Care, Inc.
DUNS: 194123980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
orphenadrine citrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code54868-4102
Application NumberANDA040284
Product Classification
M
Marketing Category
C73584
G
Generic Name
orphenadrine citrate
Product Specifications
Route of AdministrationORAL
Effective DateMay 12, 2011
FDA Product Classification
INGREDIENTS (4)
ORPHENADRINE CITRATEActive
Quantity: 100 mg in 1 1
Code: X0A40N8I4S
Classification: ACTIB
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT